Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Unusual presentation for small lymphocytic lymphoma: Case report of a man with bilateral ear involvement and review of the literature.

Tram Do B, Charpentier AM, Bourré-Tessier J, Maietta A, Doucet S, Ayad T, Christopoulos A.

Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Jun;136(3S):S45-S47. doi: 10.1016/j.anorl.2018.10.017. Epub 2019 Mar 15.

PMID:
30880035
2.

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, Hanly JG, Hiraki LT, Hussein S, Legault K, Levy D, Lim L, Matsos M, McDonald EG, Medina-Rosas J, Pardo Pardi J, Peschken C, Pineau C, Pope J, Rader T, Reynolds J, Silverman E, Tselios K, Suitner M, Urowitz M, Touma Z, Vinet E, Santesso N.

J Rheumatol. 2018 Oct;45(10):1426-1439. doi: 10.3899/jrheum.171459. Epub 2018 Sep 1.

3.

Monitoring of Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review and Metaanalysis.

Hussein S, Suitner M, Béland-Bonenfant S, Baril-Dionne A, Vandermeer B, Santesso N, Keeling S, Pope JE, Fifi-Mah A, Bourré-Tessier J.

J Rheumatol. 2018 Oct;45(10):1462-1476. doi: 10.3899/jrheum.170837. Epub 2018 Jul 1.

4.

Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus.

Jolly M, Sequeira W, Block JA, Toloza S, Bertoli A, Blazevic I, Vila LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Mok CC, Weisman M, Clarke AE, Wallace D, Alarcón G.

Arthritis Care Res (Hoboken). 2018 Apr 25. doi: 10.1002/acr.23588. [Epub ahead of print]

5.

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.

Hoa S, Troyanov Y, Fritzler MJ, Targoff IN, Chartrand S, Mansour AM, Rich E, Boudabbouz H, Bourré-Tessier J, Albert M, Goulet JR, Landry M, Senécal JL.

Scand J Rheumatol. 2018 May;47(3):210-224. doi: 10.1080/03009742.2017.1334814. Epub 2017 Oct 25.

PMID:
29065773
6.

Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.

Troyanov Y, Landon-Cardinal O, Fritzler MJ, Ferreira J, Targoff IN, Rich E, Goulet M, Goulet JR, Bourré-Tessier J, Robitaille Y, Drouin J, Albert A, Senécal JL.

Medicine (Baltimore). 2017 Jan;96(3):e5694. doi: 10.1097/MD.0000000000005694.

7.

Hereditary Heterozygous C2 Deficiency: Variable Clinical and Serological Manifestations Among Three Sisters.

Yang JW, Rich E, Saint-Cyr C, Bourré-Tessier J.

Curr Rheumatol Rev. 2017;13(2):158-160. doi: 10.2174/1573397112666160808093031.

PMID:
27502238
8.

Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.

Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourré-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Senécal JL.

Medicine (Baltimore). 2014 Nov;93(24):318-32. doi: 10.1097/MD.0000000000000222. Erratum in: Medicine (Baltimore). 2014 Nov;93(24):414.

9.

Involvement of uterine cervix as the first manifestation of granulomatosis with polyangiitis.

Caron F, Michaud R, Gariépy G, Bourré-Tessier J.

J Clin Rheumatol. 2014 Dec;20(8):458-9. doi: 10.1097/RHU.0000000000000193. No abstract available.

PMID:
25417693
10.

The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.

Bourré-Tessier J, Clarke AE, Kosinski M, Mikolaitis-Preuss RA, Bernatsky S, Block JA, Jolly M.

Lupus. 2014 Dec;23(14):1452-9. doi: 10.1177/0961203314543921. Epub 2014 Jul 31.

PMID:
25081500
11.

Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort.

Bourré-Tessier J, Urowitz MB, Clarke AE, Bernatsky S, Krantz MJ, Huynh T, Joseph L, Belisle P, Bae SC, Hanly JG, Wallace DJ, Gordon C, Isenberg D, Rahman A, Gladman DD, Fortin PR, Merrill JT, Romero-Diaz J, Sanchez-Guerrero J, Fessler B, Alarcón GS, Steinsson K, Bruce IN, Ginzler E, Dooley MA, Nived O, Sturfelt G, Kalunian K, Ramos-Casals M, Petri M, Zoma A, Pineau CA.

Arthritis Care Res (Hoboken). 2015 Jan;67(1):128-35. doi: 10.1002/acr.22370.

12.

Increased incidence of liver enzymes abnormalities in patients treated with isoniazid in combination with disease modifying and/or biologic agents.

Bourré-Tessier J, Arino-Torregrosa M, Choquette D.

Clin Rheumatol. 2014 Aug;33(8):1049-53. doi: 10.1007/s10067-014-2528-z. Epub 2014 Feb 21.

PMID:
24554383
13.

Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.

Bourré-Tessier J, Clarke AE, Mikolaitis-Preuss RA, Kosinski M, Bernatsky S, Block JA, Jolly M.

J Rheumatol. 2013 Aug;40(8):1327-33. doi: 10.3899/jrheum.121129. Epub 2013 Jun 15.

PMID:
23772082
14.

Association of smoking with cutaneous manifestations in systemic lupus erythematosus.

Bourré-Tessier J, Peschken CA, Bernatsky S, Joseph L, Clarke AE, Fortin PR, Hitchon C, Mittoo S, Smith CD, Zummer M, Pope J, Tucker L, Hudson M, Arbillaga H, Esdaile J, Silverman E, Chédeville G, Huber AM, Belisle P; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus 1000 Canadian Faces of Lupus Investigators, Pineau CA.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1275-80. doi: 10.1002/acr.21966.

15.

Features associated with cardiac abnormalities in systemic lupus erythematosus.

Bourré-Tessier J, Huynh T, Clarke AE, Bernatsky S, Joseph L, Belisle P, Pineau CA.

Lupus. 2011 Dec;20(14):1518-25. doi: 10.1177/0961203311420318. Epub 2011 Oct 4.

PMID:
21971202
16.

Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus.

Bourré-Tessier J, Clarke AE, Huynh T, Bernatsky S, Joseph L, Belisle P, Pineau CA.

Arthritis Care Res (Hoboken). 2011 Jul;63(7):1031-7. doi: 10.1002/acr.20470.

17.

Indigenous Lyme disease in Quebec.

Bourré-Tessier J, Milord F, Pineau C, Vinet E.

J Rheumatol. 2011 Jan;38(1):183. doi: 10.3899/jrheum.100768. No abstract available.

PMID:
21196590
18.

Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis.

Katchamart W, Bourré-Tessier J, Donka T, Drouin J, Rohekar G, Bykerk VP, Haraoui B, Leclerq S, Mosher DP, Pope JE, Shojania K, Thomson J, Thorne JC, Bombardier C; Canadian 3e Initiative Consensus Group.

J Rheumatol. 2010 Jul;37(7):1422-30. doi: 10.3899/jrheum.090978. Epub 2010 Jun 1. Review.

19.

Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review.

Bourré-Tessier J, Haraoui B.

J Rheumatol. 2010 Jul;37(7):1416-21. doi: 10.3899/jrheum.090153. Epub 2010 May 1. Review.

PMID:
20436072
20.

Disseminated Histoplasma capsulatum infection presenting with panniculitis and focal myositis in rheumatoid arthritis treated with etanercept.

Bourré-Tessier J, Fortin C, Belisle A, Desmarais E, Choquette D, Senécal JL.

Scand J Rheumatol. 2009;38(4):311-6. doi: 10.1080/03009740902776935. Review.

PMID:
19444717

Supplemental Content

Loading ...
Support Center